International audienceRATIONALE: Pulmonary arterial hypertension (PAH) is a progressive and fatal disease characterized by pulmonary arterial muscularization due to excessive pulmonary vascular cell proliferation and migration, a phenotype dependent upon growth factors and activation of receptor tyrosine kinases (RTKs). p130(Cas) is an adaptor protein involved in several cellular signaling pathways that control cell migration, proliferation, and survival. OBJECTIVES: We hypothesized that in experimental and human PAH p130(Cas) signaling is overactivated, thereby facilitating the intracellular transmission of signal induced by fibroblast growth factor (FGF)2, epidermal growth factor (EGF), and platelet-derived growth factor (PDGF). MEASUREME...
Summary: Pulmonary hypertension is a devastating disease characterized by excessive vascular muscula...
Rationale: Enhanced proliferation and impaired apoptosis of pulmonary arterial vascular smooth muscl...
Rationale: A hallmark of the vascular remodeling process underlying pulmonary hypertension (PH) is t...
International audienceRATIONALE: Pulmonary arterial hypertension (PAH) is a progressive and fatal di...
Pulmonary arterial hypertension (PAH) is a devastating disease characterised by progressive remodell...
Recent translational studies highlighted the inhibition of transforming growth factor (TGF)-β signal...
Recent translational studies highlighted the inhibition of transforming growth factor (TGF)-β signal...
RATIONALE: Idiopathic pulmonary arterial hypertension (IPAH) is characterized by medial hypertrophy ...
Pulmonary arterial hypertension (PAH), at one time a largely overlooked disease, is now the subject ...
RATIONALE: BMP9 (bone morphogenetic protein 9) is a circulating endothelial quiescence factor with p...
Background: The p38 Mitogen Activated Protein Kinase (MAPK) system is increasingly recognised as an ...
International audienceThe lack of curative options for pulmonary arterial hypertension drives import...
Rationale: BMP9 (bone morphogenetic protein 9) is a circulating endothelial quiescence factor with p...
10 pages; Present address of G. Hansmann: Dept. of Cardiology, Children's Hospital Boston, Harvard M...
Enhanced signaling via RTKs in pulmonary hypertension (PH) impedes current treatment options because...
Summary: Pulmonary hypertension is a devastating disease characterized by excessive vascular muscula...
Rationale: Enhanced proliferation and impaired apoptosis of pulmonary arterial vascular smooth muscl...
Rationale: A hallmark of the vascular remodeling process underlying pulmonary hypertension (PH) is t...
International audienceRATIONALE: Pulmonary arterial hypertension (PAH) is a progressive and fatal di...
Pulmonary arterial hypertension (PAH) is a devastating disease characterised by progressive remodell...
Recent translational studies highlighted the inhibition of transforming growth factor (TGF)-β signal...
Recent translational studies highlighted the inhibition of transforming growth factor (TGF)-β signal...
RATIONALE: Idiopathic pulmonary arterial hypertension (IPAH) is characterized by medial hypertrophy ...
Pulmonary arterial hypertension (PAH), at one time a largely overlooked disease, is now the subject ...
RATIONALE: BMP9 (bone morphogenetic protein 9) is a circulating endothelial quiescence factor with p...
Background: The p38 Mitogen Activated Protein Kinase (MAPK) system is increasingly recognised as an ...
International audienceThe lack of curative options for pulmonary arterial hypertension drives import...
Rationale: BMP9 (bone morphogenetic protein 9) is a circulating endothelial quiescence factor with p...
10 pages; Present address of G. Hansmann: Dept. of Cardiology, Children's Hospital Boston, Harvard M...
Enhanced signaling via RTKs in pulmonary hypertension (PH) impedes current treatment options because...
Summary: Pulmonary hypertension is a devastating disease characterized by excessive vascular muscula...
Rationale: Enhanced proliferation and impaired apoptosis of pulmonary arterial vascular smooth muscl...
Rationale: A hallmark of the vascular remodeling process underlying pulmonary hypertension (PH) is t...